Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia

Progress in Neuro-psychopharmacology & Biological Psychiatry
Anya PedersenM Rothermundt

Abstract

Astrocyte activation indicated by increased S100B is considered a potential pathogenic factor for schizophrenia. To investigate the relationship between astrocyte activation and cognitive performance, S100B serum concentration, memory performance, and psychopathology were assessed in 40 first-episode and 35 chronic schizophrenia patients upon admission and after four weeks of treatment. Chronic schizophrenia patients with high S100B were impaired concerning verbal memory performance (AVLT, Auditory Verbal Learning Test) compared to chronic and first-episode patients with low S100B levels. The findings support the hypothesis that astrocyte activation might contribute to the development of cognitive dysfunction in schizophrenia.

References

Jan 1, 1992·Neuroscience and Behavioral Physiology·L A GromovG V Ovinova
Jul 23, 1998·Neuropsychology·R W Heinrichs, K K Zakzanis
Jun 5, 1999·Biological Psychiatry·M WiesmannH Kirchner
Feb 27, 2001·Neurobiology of Learning and Memory·G WinocurN Lobaugh
Mar 5, 2004·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Matthias RothermundtVolker Arolt
Jul 9, 2004·Molecular Psychiatry·M RothermundtV Arolt
Nov 4, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Matthias RothermundtBettina Pfleiderer
Nov 7, 2006·Neurochemistry International·Daniel KondziellaUrsula Sonnewald
Apr 27, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Asli SarandolEmre Sarandol

❮ Previous
Next ❯

Citations

Dec 12, 2013·Biomarkers in Medicine·Brett A EnglishLarry Ereshefsky
Aug 22, 2014·Acta Neuropsychiatrica·Noortje W A van de KerkhofWillem M A Verhoeven
May 28, 2013·BMC Psychiatry·Kara O'ConnellKumlesh K Dev
Jun 21, 2014·Schizophrenia Research·Hans-Gert BernsteinBernhard Bogerts
Jun 15, 2011·Brain, Behavior, and Immunity·Urs Meyer
Jun 1, 2010·Journal of Psychiatric Research·Xiang Yang ZhangThomas R Kosten
Nov 26, 2009·Journal of Psychiatric Research·Xiang Yang ZhangThomas R Kosten
Feb 27, 2013·Psychiatry and Clinical Neurosciences·Silvia Yelmo-CruzPedro Abreu-González
Sep 1, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Marie-Caroline CotelAnthony C Vernon
Sep 9, 2015·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Romina Mizrahi
Jul 6, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Li TianXiang Yang Zhang
Dec 4, 2014·Schizophrenia Research·Meng XiaMikhail Pletnikov
Mar 31, 2010·The International Journal of Neuropsychopharmacology·Akihiro TakanoTetsuya Suhara
Sep 10, 2014·PloS One·Katina AleksovskaAlessandra Frustaci
Aug 16, 2016·Mediators of Inflammation·Stefano MariniMassimo Di Giannantonio
Sep 29, 2017·Tissue Barriers·Conor Delaney, Matthew Campbell
Apr 25, 2017·The Psychiatric Quarterly·Huiqiong DengOlaoluwa O Okusaga
Jul 18, 2017·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Erman EsnafogluTevfik Noyan
Feb 7, 2018·Journal of Psychiatric Research·Tanya T NguyenDilip V Jeste
Dec 11, 2019·Neuroscience and Biobehavioral Reviews·Bogdana Golofast, Karel Vales

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.